Research Funding extended for E112K as a Novel Therapy for IBD

The Broad Medical Research Program at the Crohn’s & Colitis Foundation of America has extended their Inflammatory Bowel Disease Grant to Norton Lab for a second year. The project, entitled E112K as a Novel Therapy for Irritable Bowel Disease (IBD), was inspired by Dr. Norton observing in the course of her adjuvant research the novel anti-inflammatory …

Continue reading